Table.
Comparisons of VEGF and sCD146 ELISA Levels in Vitreous Samples from Patients with PDR With or Without Active Neovascularization and Nondiabetic Patients With Rhegmatogenous RD
| Disease Group | VEGF (pg/mL) | sCD146 (pg/mL) |
|---|---|---|
| RD (n = 27), median (IQR) | 132.4 (54.5–200.0) | 79.2 (38.7–119.7) |
| All PDR (n = 41), median (IQR) | 567.1 (212.4–1235.1) | 234.2 (91.6–322.1) |
| P (Mann–Whitney test) | 0.002* | <0.001* |
| Active PDR (n = 12), median (IQR) | 1646.7 (618.6–2147.1) | 387.2 (331.3–496.1) |
| Inactive PDR (n = 29), median (IQR) | 418.4 (143.7–1075.1) | 167.2 (67.6–270.2) |
| RD (n = 27), median (IQR) | 132.4 (54.5–200.0) | 79.2 (38.7–119.7) |
| P (Kruskal–Wallis test) | <0.001* | <0.001* |
*
Statistically significant at 5% level of significance.